IART

13.2502.21%
CS

Christian S. Schade

Independent Director

Mr. Christian S. Schade, also known as Chris, is Director of Novira Therapeutics, Inc. He is Executive Chairman of RQ Biotechnology Limited from June 2026. He joined the Novira Therapeutics, Inc. on March 19, 2014. He is Independent Director of Integra LifeSciences Holdings Corporation from 2006. He joined the Integra LifeSciences Holdings Corporation in 2006. He is Director of Integra LifeSciences Corporation from 2006. He is Director of Sapience Therapeutics, Inc. from May 11, 2017. He joined the Sapience Therapeutics, Inc. on May 11, 2017. He is Chairman of the Board of CATALYM GmbH from April 2026. He is CEO, President & Director of Halda Therapeutics, LLC from October 2024. He is President, CEO & Director of Halda Therapeutics Inc. He is Senior Advisor of Frazier Life Sciences Management, LP from April 29, 2026. He was Non-Executive Director of Indivior Pharmaceuticals, Inc. from November 04, 2014 to July 31, 2019. He was employed at Indivior Pharmaceuticals, Inc. from November 04, 2014 to July 31, 2019. He was CFO, Principal Accounting Officer and Senior VP of Finance & Administration of Medarex, Inc. He was employed at Medarex, Inc. from October 2000 to September 2009. He was Chairman of the Board of Aprea Therapeutics AB from 2023. He was Executive Chairman of the Board of Aprea Therapeutics AB from August 2022 to 2023. He was CEO & Chairman of Aprea Therapeutics AB. He was President, CEO & Chairman of Aprea Therapeutics AB from September 2020. He was President, CEO & Director of Aprea Therapeutics AB from June 2016 to September 2020. He joined the Aprea Therapeutics AB in June 2016. He was Chief Financial Officer, Principal Accounting Officer and Executive Vice President of Omthera Pharmaceuticals, Inc. He was employed at Omthera Pharmaceuticals, Inc. from September 2011 to July 18, 2013. He was Chairman of Aprea Therapeutics, Inc. from July 28, 2022 to August 23, 2023. He was Chairman & CEO of Aprea Therapeutics, Inc. until July 28, 2022. He was Director of Aprea Therapeutics, Inc. from July 28, 2022. He was employed at Aprea Therapeutics, Inc. until August 23, 2023. He was Growth Partner of Flagship Pioneering, Inc from 2023 to 2024. He was employed at Flagship Pioneering, Inc from 2023 to 2024. He was Independent Chairman of Board of Omega Therapeutics, Inc. from August 2023 to January 10, 2025. He was Director of Omega Therapeutics, Inc. from July 2023 to August 2023. He was employed at Omega Therapeutics, Inc. until January 10, 2025. He was President, CEO & Chairman of Aprea Therapeutics, Inc. from September 2020. He was President, CEO & Director of Aprea Therapeutics, Inc. from June 2016 to September 2020. He was Executive Chairman of the Board of Valo Health, Inc. from January 16, 2024 to March 2026. He was employed at Valo Health, Inc. until March 2026. He was Chairperson of Alltrna, Inc. from July 2024. He has B.A. in History from Princeton University, M.B.A. from University of Pennsylvania - The Wharton School.

公司职务